Skip to content
The Nexus
DossierENTITY

GLP-1-GIP-Lani

Coverage of GLP-1-GIP-Lani in the Nexus archive.

Earliest in view: May 14 · 11:00 UTCMost recent: May 14 · 11:00 UTC
Co-mentioned in this coverage
Timo D. Mullerperson1Institute for Diabetes and Obesity at Helmholtz Munichorganization1Peter Balazsperson1Helmholtz Munichplace1Ozempictopic1
Recent coverage
  • HEALTHMay 14 · 11:00 UTCFOX NEWS
    Experimental obesity drug outperforms traditional weight-loss treatments in early research

    Researchers have developed an experimental obesity drug called GLP-1-GIP-Lani that has shown promise in early trials, outperforming traditional weight-loss treatments. The drug combines two natural hormones with PPAR activity to improve insulin sensitivity and reduce inflammation. It aims to deliver 30% weight loss with fewer side effects.